DK0927195T3 - Fremgangsmåde til fremstilling af et plasmaproteinholdigt lægemiddel - Google Patents

Fremgangsmåde til fremstilling af et plasmaproteinholdigt lægemiddel

Info

Publication number
DK0927195T3
DK0927195T3 DK97918834T DK97918834T DK0927195T3 DK 0927195 T3 DK0927195 T3 DK 0927195T3 DK 97918834 T DK97918834 T DK 97918834T DK 97918834 T DK97918834 T DK 97918834T DK 0927195 T3 DK0927195 T3 DK 0927195T3
Authority
DK
Denmark
Prior art keywords
preparation
plasma protein
containing drug
drug
plasma
Prior art date
Application number
DK97918834T
Other languages
Danish (da)
English (en)
Inventor
Wolfgang Teschner
Yendra Linnau
Sonja Svatos
Herwig Igel
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3517640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0927195(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK0927195T3 publication Critical patent/DK0927195T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97918834T 1996-09-16 1997-09-10 Fremgangsmåde til fremstilling af et plasmaproteinholdigt lægemiddel DK0927195T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0163396A AT403989B (de) 1996-09-16 1996-09-16 Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
PCT/AT1997/000197 WO1998012225A2 (de) 1996-09-16 1997-09-10 Verfarhen zur herstellung eines plasmaprotein-hältigen arzneimittels

Publications (1)

Publication Number Publication Date
DK0927195T3 true DK0927195T3 (da) 2003-11-24

Family

ID=3517640

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97918834T DK0927195T3 (da) 1996-09-16 1997-09-10 Fremgangsmåde til fremstilling af et plasmaproteinholdigt lægemiddel

Country Status (24)

Country Link
US (3) US20020034809A1 (ko)
EP (1) EP0927195B1 (ko)
JP (1) JP2001500867A (ko)
KR (1) KR20000036002A (ko)
CN (1) CN1230967A (ko)
AR (1) AR009582A1 (ko)
AT (2) AT403989B (ko)
AU (1) AU732519B2 (ko)
BR (1) BR9712044A (ko)
CA (1) CA2265936C (ko)
CZ (1) CZ91199A3 (ko)
DE (1) DE59710700D1 (ko)
DK (1) DK0927195T3 (ko)
ES (1) ES2206701T3 (ko)
HU (1) HUP0002265A3 (ko)
ID (1) ID21224A (ko)
IL (1) IL128770A0 (ko)
IN (1) IN187314B (ko)
MX (1) MXPA99002144A (ko)
NO (1) NO991198L (ko)
PL (1) PL332159A1 (ko)
PT (1) PT927195E (ko)
SK (1) SK32899A3 (ko)
WO (1) WO1998012225A2 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AT408946B (de) * 1999-02-18 2002-04-25 Immuno Ag Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
IL162239A0 (en) 2001-12-21 2005-11-20 Novo Nordisk Healthcare Ag Liquid composition of factor vii polypeptides
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
CA2525224A1 (en) * 2003-05-23 2004-12-02 Michael Bech Jensen Protein stabilization in solution
ES2574581T3 (es) 2003-08-14 2016-06-20 Novo Nordisk Health Care Ag Composición farmacéutica líquida acuosa de polipéptidos de tipo Factor VII
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
RU2624139C2 (ru) 2011-12-05 2017-06-30 Фэктор Байосайенс Инк. Способы и препараты для трансфекции клеток
ES2381828B1 (es) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
CA3067735A1 (en) 2017-08-17 2019-02-21 Just Biotherapeutics, Inc. Method of purifying glycosylated protein from host cell galectins and other contaminants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE384134C (de) * 1921-05-07 1923-10-25 Chemisch Pharmazeutische Werke Verfahren zur Herstellung eines Kamillenextraktes
DE2331854A1 (de) * 1973-06-22 1975-01-16 Greither Salus Haus Dr Otto Verfahren zur herstellung standardisierter arzneimittel aus kamillenblueten
FR2630115B1 (fr) * 1988-04-14 1994-10-28 Merieux Inst Procede de stabilisation des solutions d'albumine humaine et solution obtenue
SE500110C2 (sv) * 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
US5250663A (en) * 1990-04-19 1993-10-05 Miles Inc. Preparing essentially monomeric normal human serum albumin
JP2949846B2 (ja) * 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
US5744586A (en) * 1996-06-26 1998-04-28 Alpha Therapeutic Corporation Manufacturing process for the production of purified transferrin
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies

Also Published As

Publication number Publication date
CA2265936C (en) 2008-04-22
AR009582A1 (es) 2000-04-26
IN187314B (ko) 2002-03-23
EP0927195A2 (de) 1999-07-07
EP0927195B1 (de) 2003-09-03
WO1998012225A3 (de) 1998-04-23
WO1998012225A2 (de) 1998-03-26
ID21224A (id) 1999-05-06
KR20000036002A (ko) 2000-06-26
US20050249815A1 (en) 2005-11-10
ATA163396A (de) 1997-12-15
BR9712044A (pt) 1999-08-24
NO991198D0 (no) 1999-03-11
AU732519B2 (en) 2001-04-26
CZ91199A3 (cs) 1999-06-16
SK32899A3 (en) 1999-08-06
ES2206701T3 (es) 2004-05-16
CN1230967A (zh) 1999-10-06
US20020034809A1 (en) 2002-03-21
ATE248857T1 (de) 2003-09-15
DE59710700D1 (de) 2003-10-09
PT927195E (pt) 2004-01-30
AT403989B (de) 1998-07-27
IL128770A0 (en) 2000-01-31
JP2001500867A (ja) 2001-01-23
CA2265936A1 (en) 1998-03-26
PL332159A1 (en) 1999-08-30
US20140234292A1 (en) 2014-08-21
US8709492B2 (en) 2014-04-29
HUP0002265A3 (en) 2003-01-28
HUP0002265A2 (hu) 2000-11-28
NO991198L (no) 1999-05-14
AU4289997A (en) 1998-04-14
MXPA99002144A (es) 2005-04-28

Similar Documents

Publication Publication Date Title
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK0916675T3 (da) Fremgangsmåde til fremstilling af sildenafil
DK0897970T3 (da) Fremgangsmåde til fremstilling af stanolestere
DK0812357T3 (da) Fremgangsmåde til fremstilling af heteromultimere polypeptider
DK0775100T3 (da) Fremgangsmåde til fremstilling af trifluorethylen
DK0905254T3 (da) Fremgangsmåde til fremstilling af en lavemolekylær
DK0927195T3 (da) Fremgangsmåde til fremstilling af et plasmaproteinholdigt lægemiddel
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0824517T3 (da) Fremgangsmåde til fremstilling af lercanidipinhydrochlorid
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK0756597T3 (da) Fremgangsmåde til fremstilling af puriner
DK0839138T3 (da) Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK0996642T3 (da) Fremgangsmåde til fremstilling af heparin
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0946531T3 (da) Fremgangsmåde til fremstilling af thiazol-derivater
DK0966444T3 (da) Fremgangsmåde til fremstilling af pyrazolderivater
DK0912603T3 (da) Fremgangsmåde til fremstilling af visse azacyclohexapeptider
DK0721453T3 (da) Fremgangsmåde til fremstilling af N-methyl-3-(1-methyl-4-piperidinyl)-14-indol-5-ethansulfonamid
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK0648738T3 (da) Fremgangsmåde til fremstilling af acetoacetarylamider
DK0929226T3 (da) Fremgangsmåde til fremstilling af et fødevareprodukt